Thyrocyte-interleukin-1 interactions

Summary:

Autoimmune thyroid disease is the most common organ-specific autoimmune disease and is a very common cause of thyroid dysfunction such as autoimmune hypothyroidism, Graves' disease and postpartum thyroiditis. The thyroid gland from patients with autoimmune thyroid disease is morphologically characterized by massive infiltration of lymphoid cells. The interleukin-1 (IL-1) family of molecules is together with other cytokines an integral component of the complex intercellular communication required to mount and control an immune response.

IL-1α/β in moderate and high concentrations reversibly inhibit thyroid cell function, while IL-1β in low concentrations stimulates thyroid cell function. The biphasic, non-cytotoxic and reversible influence of IL-1 supports a role of IL-1 in the physiological regulation of thyroid cell function. IL-1 stimulates the guanylate mediated pathways and inhibits the adenylate cyclase mediated pathways. All IL-1 effects are counteracted by IL-1 receptor antagonist indicating that the effects are exerted through activation of specific IL-1 receptors on thyrocytes. Furthermore, IL-1 induces or enhances expression of a number of immunologically active molecules such as adhesion molecules, cytokines, and complement regulatory proteins in thyroid epithelial cells. IL-1 may thus play a role during physiological as well as pathophysiological conditions contributing to for example the euthyroid sick syndrome and development of thyroid autoimmunity.

This review summarizes current litterature on the phenomenological in vitro influence of IL-1 on the thyroid cell.

Abbreviations: cAMP: cyclic adenylate monophosphate, cGMP: cyclic guanylate monophosphate, FRTL: Fischer rat thyroid line, ICAM: intercellular adhesion molecule, IL-1: interleukin-1, IL-6: interleukin-6, IL-8: interleukin-8, IL-1RA: Interleukin-1 receptor antagonist, L-NMMA: L-N^G-monomethyl-arginine, NIS: Na⁺/I^- symporter, NO: nitric oxide, rh: recombinant human, TEC: thyroid epithelial cells, Tg: thyroglobulin, TPO: thyroid peroxidase, TSH: thyrotropin

Autoimmune thyroid disease - thyrocytes - interleukin-1 - interleukin-1 receptor antagonist

References

• 1 Ajjan R A, Watson P F, Findlay C, Metcalfe R A, Crisp M, Ludgate M, Weetman A P. The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity.  J Endocrinol. 158 351-358 1998; 
• 2 Asakawa H, Hanafusa T, Oda Y, Katsura H, Miyagawa J-I, Mashita K, Kono N, Tarui S. Human recombinant interleukin 1 inhibits TSH-stimulated morphological changes in thyroid follicles cultured as semi-organs.  Acta Endocrinol (Copenh). 125 80-85 1991; 
• 3 Asakawa H, Miyagawa J-I, Kobayashi T, Hanafusa T, Kuwajima M, Matsuzawa Y. Effects of interleukin-1γβ on scanning electron microscopic appearance and thyroid peroxidase content of human thyrocytes in monolayer culture.  Immunopharm. 34 131-137 1996; 
• 4 Ashizawa K, Yamashita S, Tobinga T, Nagayama Y, Kimura H, Hirayu H, Izumi M, Nagataki S. Inhibition of human thyroid peroxidase gene expression by interleukin 1.  Acta Endocrinol (Copenh). 121 465-469 1989; 
• 5 Bendtzen K. Cytokines and natural regulators of cytokines.  Immunol Lett. 43 111-123 1994; 
• 6 Bendtzen K. Immune hormones (cytokines); pathogenic role in autoimmune rheumatic diseases and endocrine diseases.  Autoimmunity. 2 177-189 1989; 
• 7 Bendtzen K, Rasmussen Å K, Bech K, Feldt-Rasmussen U, Buschard K. Pathogenic role of interleukin 1 and tumor necrosis factor in autoimmune endocrine diseases.  Clin Immunol Newlet. 9 72-74 1988; 
• 8 Borgerson K L, Bretz J D, Baker J R. The role of Fas-mediated apoptosis in thyroid autoimmune disease.  Autoimmunity. 30 251-264 1999; 
• 9 Diamant M, Kayser L, Rasmussen Å K, Bendtzen K. Interleukin-6 production by thyroid epithelial cells. Enhancement by interleukin-1.  Autoimmunity. 11 21-26 1991; 
• 10 Estevez R, van Sande J, Dumont J. Nitric oxide as a signal in thyroid.  Mol Cell Endocrinol. 90 R1-R3 1992; 
• 11 Kasai K, Hattori Y, Nakanishi N, Manaka K, Banba N, Motohashi S, Shimoda S-I. Regulation of inducible nitric oxide production by cytokines in human thyrocytes in culture.  Endocrinol. 136 4261-4270 1995; 
• 12 Kasai K, Hiraiwa M, Emoto T, Kuroda Y, Hattori Y, Mochizuki Y, Nakamura T, Shimoda S-I. Presence of high affinity receptor for interleukin-1 (IL-1) on cultured porcine thyroid cells.  Horm Metabol Res. 22 75-79 1990; 
• 13 Kawabe Y, Eguchi K, Shimomura C, Mine M, Otsubo T, Ueki Y, Tezuka H, Nakao H, Kawakami A, Migita K, Yamashita S, Matsunaga A, Ishikawa N, Ito K, Nagataki S. Interleukin-1 production and action in thyroid tissue.  J Clin Endocrinol Metab. 68 1174-1183 1989; 
• 14 Kennedy R L, Jones T H. Cytokines in endocrinology: their roles in health and in disease.  J Endocrinol. 129 167-178 1991; 
• 15 Kennedy R L, Jones T H, Davies R, Justice S K, Lemoine N R. Release of interleukin-6 by human thyroid epithelial cells immortalized by simian virus 40 DNA transfection.  J Endocrinol. 133 477-482 1992; 
• 16 Kimura H, Yamashita S, Namba H, Tominaga T, Tsuruta M, Yokoyama N, Izumi M, Nagataki S. Interleukin-1 inhibits human thyroid carcinoma cell growth.  J Clin Endocrinol Metab. 75 596-602 1992; 
• 17 Kung A W, Lau K S. Interleukin-1 beta modulates thyrotropin-induced thyroglobulin mRNA transcription through 3′,5′-cyclic adenosine monophosphate.  Endocrinol. 127 1369-1374 1990; 
• 18 Millatt L J, Jackson R, Williams B C, Whitley G StJ. Nitric oxide stimulates cyclic GMP in human thyrocytes.  J Mol Endocrinol. 10 163-169 1993; 
• 19 Mine M, Tramontano D, Chin W C, Ingbar S H. Interleukin 1 stimulates thyroid cell growth and increases the concentration of the c-myc proto-oncogene mRNA in thyroid follicular cells in culture.  Endocrinol. 120 1212-1214 1987; 
• 20 Nilsson M, Husmark J, Bjorkman U, Ericson L E. Cytokines and thyroid epithelial integrity: interleukin-1 alpha induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes.  J Clin Endocrinol Metab. 83 945-952 1998; 
• 21 Pang X-P, Hershman J M, Smith V, Pekary A E, Sugawara M. The mechanism of action of tumor necrosis factor-γα and interleukin-1 on FRTL-5 cells.  Acta Endocrinol (Copenh). 123 203-210 1990; 
• 22 Paolieri F, Salmaso C, Battifora M, Montagna P, Pesce G, Bagnasco M, Richiusa P, Galluzzo A, Giordano C. Possible pathogenetic relevance of interleukin-1 beta in “destructive” organ-specific autoimmune disease (Hashimoto's thyroiditis).  Ann N Y Acad Sci. 876 221-228 1999; 
• 23 Pekary A E, Berg L, Santini F, Chopra I, Hershman J M. Cytokines modulate type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cells.  Mol Cell Endocrinol. 101 R31-R35 1994; 
• 24 Rasmussen Å K, Bech K, Feldt-Rasmussen U, Poulsen S, Holten I, Ryberg M, Dinarello C A, Siersbæk-Nielsen K, Friis T, Bendtzen K. Interleukin-1β affects the function of cultured human thyroid cells.  Allergy. 43 435-441 1988; 
• 25 Rasmussen Å K, Diamant M, Blichert-Toft M, Bendtzen K, Feldt-Rasmussen U. The effects of interleukin (IL)-1γβ on human thyrocyte functions are counteracted by the IL-1 receptor antagonist.  Endocrinol. 138 2043-2048 1997; 
• 26 Rasmussen Å K, Di Marco R, Diamant M, Feldt-Rasmussen U, Bendtzen K. Nitric oxide production is not involved in the effects of interleukin-1γβ on cAMP, thyroglobulin and interleukin-6 in TSH-stimulated human thyroid cells.  Autoimmunity. 19 239-245 1994;  , (Authors' Corrigendum in Autoimmunity 23: 289, 1996)
• 27 Rasmussen Å K, Kayser L, Bech K, Feldt-Rasmussen U, Perrild H, Bendtzen K. Differential effects of interleukin 1γα and 1β on cultured human and rat thyroid cells.  Acta Endocrinol. 122 520-526 1990; 
• 28 Reimers J, Rasmussen Å K, Karlsen A E, Bjerre U, Liang H, Morin O, Andersen H U, Mandrup-Poulsen T, Burger A, Feldt-Rasmussen U, Nerup J. Interleukin-1γβ inhibits rat thyroid cell function in vivo and in vitro by an NO independent mechanism and induces hypothyroidism and accelerated thyroiditis in diabetes-prone BB rats.  J Endocrinol. 151 147-157 1996; 
• 29 Sato K, Satoh T, Shizume K, Ozawa M, Han D C, Imamura H, Tsushima T, Demura H, Kanaji Y, Ito Y, Obara T, Fujimoto Y, Kanaji Y. Inhibition of ¹²⁵I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-γα, and interferon-γγ in human thyrocytes in suspension culture.  J Clin Endocrinol Metab. 70 1735-1743 1990; 
• 30 Shong M, Ro H K, Kim Y K, Yoo C J, Lee J H, Song C U, Cho B Y. The cytokines, interleukin-1γβ interleukin-6 and interferon-γγ upregulate the expression of intercellular adhesion molecule-1 (ICAM-1) in rat thyroid cell line, FRTL-5.  Kor J Int Med. 9 88-92 1994; 
• 31 Svenson M, Hansen M B, Kayser L, Rasmussen Å K, Reimert C M, Bendtzen K. Effects of human anti-IL-1γα autoantibodies on receptor binding and biological activities of IL-1.  Cytokine. 4 125-133 1992; 
• 32 Svenson M, Kayser L, Hansen M B, Rasmussen Å K, Bendtzen K. Interleukin 1 receptor on human thyroid cells and on the rat thyroid cell line FRTL 5.  Cytokine. 3 125-130 1991; 
• 33 Tandon N, Dinsdale C, Tamatani T, Miyasaka M, Weetman A P. Adhesion molecule expression by the FRTL-5 rat thyroid cell line.  J Endocrinol. 130 451-456 1991; 
• 34 Tandon N, Morgan B P, Weetman A P. Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells.  Immunol. 75 372-377 1992; 
• 35 Tolosa E, Roura C, Martí M, Belfiore A, Pujol-Borrell R. Induction of intercellular adhesion molecule-1 but not of lymphocyte function-associated antigen-3 in thyroid follicular cells.  J Autoimmun. 5 119-135 1992; 
• 36 Watson P F, Pickerill A P, Davies R, Weetman A P. Semi-quantitative analysis of interleukin-1γα, interleukin-6 and interleukin-8 mRNA expression by human thyrocytes.  J Mol Endocrinol. 15 11-21 1995; 
• 37 Weetman A P, Ajjan R A, Watson P F. Cytokines and Graves' disease.  Baillière's Clin Endocrinol Metab. 11 481-497 1997; 
• 38 Weetman A P, Bennett G L, Wong W LT. Thyroid follicular cells produce interleukin-8.  J Clin Endocrinol Metab. 75 328-330 1992 a; 
• 39 Weetman A P, Cohen S, Makgoba M W, Borysiewicz L K. Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cells.  J Endocrinol. 122 185-191 1989; 
• 40 Weetman A P, Freeman M, Morgan B P. Thyroid follicular cell function after non-lethal complement membrane attack.  Clin Exp Immunol. 82 69-74 1990; 
• 41 Weetman A P, Tandon N, Morgan B P. Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells.  Lancet. 340 633-636 1992 b; 
• 42 Yamashita S, Kimura K, Ashizawa Y, Nagayama Y, Hiraya H, Izumi M, Nagataki S. Interleukin-1 inhibits thyrotropin-induced human thyroglobulin gene expression.  J Endocrinol. 122 177-183 1989; 
• 43 Yip I, Pang X-P, Berg L, Hershman J M. Antitumor actions of interferon-γγ and interleukin-1γβ on human papillary thyroid carcinoma cell lines.  J Clin Endocrinol Metab. 80 1664-1669 1995; 
• 44 Zeki K, Azuma H, Suzuki H, Morimoto I, Eto S. Effects of interleukin 1 on growth and adenosine 3′,5′-monophosphate generation of the rat thyroid cell line FRTL5 cells.  Acta Endocrinol (Copenh). 124 (1) 60-66 1991; 
• 45 Zeki K, Nakano Y, Inokuchi N, Watanabe K, Morimoto I, Yamashita U, Eto S. Autocrine stimulation of interleukin-1 in the growth of human thyroid carcinoma cell line NIM1.  J Clin Endocrinol Metab. 76 127-133 1993;